ATE450274T1 - Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen - Google Patents

Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Info

Publication number
ATE450274T1
ATE450274T1 AT03738319T AT03738319T ATE450274T1 AT E450274 T1 ATE450274 T1 AT E450274T1 AT 03738319 T AT03738319 T AT 03738319T AT 03738319 T AT03738319 T AT 03738319T AT E450274 T1 ATE450274 T1 AT E450274T1
Authority
AT
Austria
Prior art keywords
hydroxypropymethacrylamide
conjugates
nuclide activation
methacrylate copolymers
anticancer compounds
Prior art date
Application number
AT03738319T
Other languages
English (en)
Inventor
Bipin C Patel
Original Assignee
Psimei Pharmaceuticals Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals Plc filed Critical Psimei Pharmaceuticals Plc
Application granted granted Critical
Publication of ATE450274T1 publication Critical patent/ATE450274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
AT03738319T 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen ATE450274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02255107 2002-07-22
PCT/GB2003/002919 WO2004009136A2 (en) 2002-07-22 2003-07-04 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds

Publications (1)

Publication Number Publication Date
ATE450274T1 true ATE450274T1 (de) 2009-12-15

Family

ID=30470320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03738319T ATE450274T1 (de) 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Country Status (9)

Country Link
US (1) US7662360B2 (de)
EP (1) EP1534347B1 (de)
JP (1) JP2006502993A (de)
CN (2) CN1678353A (de)
AT (1) ATE450274T1 (de)
AU (2) AU2003244843B2 (de)
CA (1) CA2493252A1 (de)
DE (1) DE60330355D1 (de)
WO (2) WO2004009136A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115457A2 (en) * 2004-05-10 2005-12-08 University Of Utah Research Foundation Combined active and passive targeting of biologically active agents
EP1797427A4 (de) * 2004-09-22 2009-04-08 Odyssey Thera Inc Verfahren zur identifizierung neuer arzneimittel-leads und neuer therapeutischer verwendungen für bekannte arzneimittel
WO2010042638A2 (en) * 2008-10-07 2010-04-15 Young Bok Lee Hpma - docetaxel or gemcitabine conjugates and uses therefore
CA2768149A1 (en) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for hiv disease
US8715986B2 (en) * 2009-10-29 2014-05-06 Lucia Irene Gonzalez Stereoisomer peptides, ligand-targeted multi- stereoisomer peptide polymer conjugates, and uses thereof
EP2774625B1 (de) * 2011-09-05 2017-04-12 Hiroshi Maeda Fluoreszierende poylmermolekülsonde
JP6253008B2 (ja) * 2013-08-27 2017-12-27 国立大学法人 筑波大学 高分子化ホウ素化合物及びその使用
WO2015156385A1 (ja) * 2014-04-11 2015-10-15 国立研究開発法人産業技術総合研究所 ホウ素化合物を内包および外壁に担持するカーボンナノホーン及びその製造方法
CZ308742B6 (cs) 2015-01-14 2021-04-21 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro izolaci, imobilizaci a vizualizaci proteinů
CZ308807B6 (cs) * 2015-01-14 2021-06-02 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro vizualizaci a separaci proteinů a buněk
CN105503918A (zh) * 2015-12-08 2016-04-20 南京林业大学 一种含二氧杂戊硼基卟啉锌配合物及其制备方法
CN105777790B (zh) * 2016-05-17 2017-11-14 南京远淑医药科技有限公司 一种邻碳硼烷苯酚衍生物及其制备方法和应用
US11801307B2 (en) 2016-10-14 2023-10-31 University Of Utah Research Foundation Antibody-polymer-drug conjugates
CN107163097B (zh) * 2017-04-20 2020-04-14 童永彭 环磷酸腺苷硼酸络合物及其制备方法,以及抗肿瘤药物和中子俘获治疗的硼剂
JP7219925B2 (ja) * 2018-02-20 2023-02-10 国立大学法人東京工業大学 p-ボロノフェニルアラニン誘導体及びそれを含む組成物、並びにそれらを製造するためのキット
JP7440914B2 (ja) * 2018-06-20 2024-02-29 国立大学法人弘前大学 ホウ素中性子捕捉療法用の腫瘍組織を短時間で選択的ないし局所的に標的化できる集積性ボロン10薬剤
EP3852768A4 (de) * 2018-09-20 2022-09-14 Glyscend, Inc. Boronsäurepolymere und verwendungsverfahren
JP2022548699A (ja) 2019-09-20 2022-11-21 グライセンド, インコーポレイテッド 置換フェニルボロン酸含有ポリマーおよび使用方法
JP2021063033A (ja) * 2019-10-11 2021-04-22 国立大学法人 東京大学 環状ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856551A (en) * 1993-03-12 1999-01-05 The Regents Of The University Of California Macromolecular structure for boron neutron-capture therapy
US6180766B1 (en) * 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
JPH07206690A (ja) * 1994-01-14 1995-08-08 Seitai Kagaku Kenkyusho:Kk 癌治療薬およびその中間体
US6017902A (en) * 1999-02-25 2000-01-25 Brookhaven Science Associates Boron containing amino acid compounds and methods for their use

Also Published As

Publication number Publication date
CN101524549A (zh) 2009-09-09
DE60330355D1 (de) 2010-01-14
CA2493252A1 (en) 2004-01-29
WO2004009136A3 (en) 2004-04-08
AU2003250391A8 (en) 2004-02-09
AU2003244843B2 (en) 2008-06-19
CN1678353A (zh) 2005-10-05
AU2003244843A1 (en) 2004-02-09
EP1534347B1 (de) 2009-12-02
JP2006502993A (ja) 2006-01-26
WO2004009136A2 (en) 2004-01-29
WO2004009135A2 (en) 2004-01-29
US7662360B2 (en) 2010-02-16
EP1534347A2 (de) 2005-06-01
WO2004009135A3 (en) 2004-05-06
US20070258891A1 (en) 2007-11-08
AU2003250391A1 (en) 2004-02-09
HK1077513A1 (en) 2006-02-17

Similar Documents

Publication Publication Date Title
DE60330355D1 (de) Konjugate von n-hydroxypropymethacrylamid-methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs-verbindungen
ATE507845T1 (de) Polyacetal-arzneimittelkonjugate als freisetzungssystem
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
ATE381921T1 (de) Haarpflegezusammensetzungen
WO2008076333A3 (en) Polymer-drug conjugates with tether groups for controlled drug delivery
TR200101751T2 (tr) Poliol-IFN-beta konjugatları
DE60004172D1 (de) Gcsf konjugate
DE50102595D1 (de) Kosmetisches mittel
BR0317296A (pt) Método de tratamento de uma formação subterrânea
ATE515290T1 (de) Körperpflegezusammensetzungen mit glycerin und hydroxypropyl-quarternär-ammoniumsalzen
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
WO2007064345A3 (en) Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
CY1109996T1 (el) Ανοσογονικη συνθεση
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
WO2006060533A3 (en) Conjugates of 1, 8-bis-naphthalimides with an antibody
MX2009006410A (es) Conjugados de polimero-oligonucleotido, proteina y/o peptido.
TW200716151A (en) Polymeric derivative of cytidine metabolic antagonist
DK1327146T3 (da) Forbindelse med et forgrenet linkermolekyle
DK1237584T3 (da) Receptorbindende konjugater
EP1379508A4 (de) N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
GB2436996B (en) Rigid amines
MX2021003295A (es) Enlazadores basados en sulfomaleimida y sus correspondientes conjugados.
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
WO2005027828A3 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties